Inclusive Clinical Trial Design for Rare Diseases: 2026 Guide

Clinical trials for rare diseases often fail not because treatments don't work, but because they're designed for patients who don't exist. With 300-400 million people affected by over 7,000 rare diseases, the future demands a radical shift: building inclusive, patient-centered trials that adapt to real-world diversity rather than forcing patients into rigid protocols.